Total Funding
85
79
Total FundingSeries D raised
Growth Score
-10 pts
Heat Score
21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15060
Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.
Martin Goldberg: Vice President, Product DevelopmentPast Role: SlipChip, Senior Vice President, Research & Development- Omid Farokhzad: CEOPast Role: Tarveda Therapeutics, Founder & Director
About the Company
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological
diseases, drive earlier treatment and improve patient outcomes.
